IN8bio

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IN8bio and other ETFs, options, and stocks.

About INAB

IN8bio, Inc. operates as a clinical stage biopharmaceutical company, which focuses on developing novel therapies for the treatment of cancers, including solid tumors, by employing allogeneic, autologous and genetically modified gamma-delta T cells. The company was founded by Lawrence S. 

CEO
William T. Ho
CEOWilliam T. Ho
Employees
17
Employees17
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
2016
Founded2016
Employees
17
Employees17

INAB Key Statistics

Market cap
10.42M
Market cap10.42M
Price-Earnings ratio
-0.56
Price-Earnings ratio-0.56
Dividend yield
Dividend yield
Average volume
66.71K
Average volume66.71K
High today
$1.05
High today$1.05
Low today
$0.9802
Low today$0.9802
Open price
$1.00
Open price$1.00
Volume
57.92K
Volume57.92K
52 Week high
$2.73
52 Week high$2.73
52 Week low
$0.90
52 Week low$0.90

Stock Snapshot

As of today, IN8bio(INAB) shares are valued at $1.01. The company's market cap stands at 10.42M, with a P/E ratio of -0.56.

As of 2026-08-12, IN8bio(INAB) stock has fluctuated between $0.98 and $1.05. The current price stands at $1.01, placing the stock +3.1% above today's low and -3.8% off the high.

IN8bio(INAB) shares are trading with a volume of 57.92K, against a daily average of 66.71K.

During the past year, IN8bio(INAB) stock moved between $0.90 at its lowest and $2.73 at its peak.

During the past year, IN8bio(INAB) stock moved between $0.90 at its lowest and $2.73 at its peak.

INAB News

TipRanks 6d
IN8bio reports Q2 EPS (25c), consensus (37c)

“The second quarter marked an important period of scientific and clinical validation for gammadelta T cell therapeutics and IN8bio (INAB). Our gammadelta TCE pl...

People also own

Based on the portfolios of people who own INAB. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.